Home › RXi Pharmaceuticals Corp (RXII) Downgraded by Zacks Investment Research to "Sell"
 

Keywords :   


RXi Pharmaceuticals Corp (RXII) Downgraded by Zacks Investment Research to "Sell"

2015-12-19 21:28:21| Biotech - Topix.net

According to Zacks, "RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor.

Tags: research sell investment corp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10'Rightmove is my porn' - the addiction to online property search
06.10Eastern North Pacific Tropical Weather Outlook
06.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
More »